NBE-Therapeutics AG logo

NBE-Therapeutics AG Employee Directory

Biotechnology ResearchBasel-Stadt, Switzerland11-50 Employees

NBE-Therapeutics AG is a Basel-based biotechnology company focused on oncology research, developing next-generation antibody-drug conjugates aimed at solid tumors. Through its in-house technologies, the firm seeks to deliver targeted cancer therapies that produce a durable immune-oncology effect with the potential to shrink or eradicate tumors. It maintains an international team and operates a pipeline of ADC product candidates at various development stages intended to advance into clinical testing for cancer patients who need more selective treatment options.

In 2025, the company expanded its Basel operations, inaugurating a new antibody-drug conjugate research and development facility in Basel. Positioned within the biotechnology research industry, the organization is a small to mid-sized enterprise with Basel-based roots and an international team supporting its research and development activities.

Find NBE-Therapeutics AG employees' phone numbers or email addresses

NBE-Therapeutics AG Global Highlights

Location
Employees

Europe
44

Minus sign iconPlus sign icon
  • Switzerland
    36
  • Germany
    6
  • France
    2

North America
1

Minus sign iconPlus sign icon
  • United States Of America
    1

NBE-Therapeutics AG's Leadership

  • Chief Scientific Officer at NBE-Therapeutics AG
    C. D.
    Chief Scientific Officer
  • Head Of In Vivo Unit at NBE-Therapeutics AG
    M. M.
    Head Of In Vivo Unit
  • Head Of Conjugation at NBE-Therapeutics AG
    H. B.
    Head Of Conjugation
  • Head Of Adc Chemistry at NBE-Therapeutics AG
    N. V.
    Head Of Adc Chemistry
  • Senior Director Program Management And Pipeline Innovation at NBE-Therapeutics AG
    U. F.
    Senior Director Program Management And Pipeline Innovation
  • Director Adc Cmc at NBE-Therapeutics AG
    G. B.
    Director Adc Cmc
  • Operations Manager at NBE-Therapeutics AG
    V. M.
    Operations Manager
  • Program Manager Early Development at NBE-Therapeutics AG
    I. H.
    Program Manager Early Development

NBE-Therapeutics AG Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Program & Project Management
  • Finance
  • Human Resources
  • Other
  • Operations
  • Biotechnology
  • Education
  • Accounting
  • Business
  • Entrepreneurship

Contact profiles from NBE-Therapeutics AG

Name
Title
Contact
Location
Last Update
  • Chief Scientific Officer at NBE-Therapeutics AG
    C. D.
    Chief Scientific Officer
    Germany
    Sep 10, 2026
  • Head Of In Vivo Unit at NBE-Therapeutics AG
    M. M.
    Head Of In Vivo Unit
    Switzerland, Basel-City
    Sep 02, 2026
  • Head Of Conjugation at NBE-Therapeutics AG
    H. B.
    Head Of Conjugation
    Sep 02, 2026
  • Head Of Adc Chemistry at NBE-Therapeutics AG
    N. V.
    Head Of Adc Chemistry
    Switzerland
    Sep 02, 2026
  • Senior Director Program Management And Pipeline Innovation at NBE-Therapeutics AG
    U. F.
    Senior Director Program Management And Pipeline Innovation
    Germany, Baden-Württemberg
    Sep 10, 2026
  • Director Adc Cmc at NBE-Therapeutics AG
    G. B.
    Director Adc Cmc
    Switzerland, Basel-City
    Sep 02, 2026
  • Operations Manager at NBE-Therapeutics AG
    V. M.
    Operations Manager
    Switzerland
    Jun 27, 2026
  • Program Manager Early Development at NBE-Therapeutics AG
    I. H.
    Program Manager Early Development
    Switzerland
    Aug 27, 2026
  • Senior Scientist, Head Adc Discovery Team at NBE-Therapeutics AG
    C. L.
    Senior Scientist, Head Adc Discovery Team
    France
    Sep 02, 2026
  • Senior Scientist at NBE-Therapeutics AG
    R. G.
    Senior Scientist
    Switzerland
    Sep 15, 2026

Frequently Asked Questions

What is NBE-Therapeutics AG known for?

Minus sign iconPlus sign icon
NBE-Therapeutics AG operates in the Biotechnology Research industry. Explore NBE-Therapeutics AG's company overview page for more information.

What is NBE-Therapeutics AG's most common email format?

Minus sign iconPlus sign icon
NBE-Therapeutics AG employees' email format typically follows the pattern of First.Last@nbe-therapeutics.com. Trying to find reliable and up-to-date employee contact data? Find more NBE-Therapeutics AG email formats with LeadIQ.

How many employees does NBE-Therapeutics AG have currently?

Minus sign iconPlus sign icon
NBE-Therapeutics AG has approximately 48 employees as of August 2026. These team members are located across 2 continents, including Europe and North America.

Who are NBE-Therapeutics AG's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, NBE-Therapeutics AG's key employees include:

  • Chief Scientific Officer: C. D.
  • Head Of In Vivo Unit: M. M.
  • Head Of Conjugation: H. B.
  • Head Of Adc Chemistry: N. V.
  • Senior Director Program Management And Pipeline Innovation: U. F.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.